Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Chase

Showing results (21-30 of 397) with videos related to

Pageof 40
Sort By:
Advances in Neurology|January 1, 1975
Dopaminergic mechanisms in patients with extrapyramidal diseaseT N Chase, I Shoulson
The New England Journal of Medicine|October 17, 1974
Letter: Fenfluramine and dyskinesiasI Shoulson, T N Chase
Neurology|October 1, 1976
Central monoamines and hyperkinase of childhoodT Shetty, T N Chase
Postgraduate Medical Journal|January 1, 1975
Behavioural and biochemical effects of fenfluramine in patients with neurologic diseaseT N Chase, I Shoulson
Lancet (London, England)|June 2, 1973
Methyldopa or methyldopahydrazine as levodopa synergistsJ Fermaglich, T N Chase
European Journal of Pharmacology|February 9, 1993
Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulationC Marin, T N Chase
Annual Review of Medicine|January 1, 1975
Huntington's diseaseI Shoulson, T N Chase
Amino Acids|October 10, 2002
Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's diseaseJ D Oh, T N Chase
Annals of Neurology|May 1, 1996
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeysS M Papa, T N Chase
Experimental Neurology|March 1, 1997
Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complicationsM M Mouradian, T N Chase
Pageof 40

Showing results (21-30 of 397) with videos related to

Sort By:
Pageof 40
Advances in Neurology|January 1, 1975
Dopaminergic mechanisms in patients with extrapyramidal diseaseT N Chase, I Shoulson
The New England Journal of Medicine|October 17, 1974
Letter: Fenfluramine and dyskinesiasI Shoulson, T N Chase
Neurology|October 1, 1976
Central monoamines and hyperkinase of childhoodT Shetty, T N Chase
Postgraduate Medical Journal|January 1, 1975
Behavioural and biochemical effects of fenfluramine in patients with neurologic diseaseT N Chase, I Shoulson
Lancet (London, England)|June 2, 1973
Methyldopa or methyldopahydrazine as levodopa synergistsJ Fermaglich, T N Chase
European Journal of Pharmacology|February 9, 1993
Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulationC Marin, T N Chase
Annual Review of Medicine|January 1, 1975
Huntington's diseaseI Shoulson, T N Chase
Amino Acids|October 10, 2002
Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's diseaseJ D Oh, T N Chase
Annals of Neurology|May 1, 1996
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeysS M Papa, T N Chase
Experimental Neurology|March 1, 1997
Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complicationsM M Mouradian, T N Chase
Pageof 40